Source: International Congress 2018 – Management of bronchiectasis and large airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
. Nagiieva (Dnipro, Ukraine), T. Pertseva (Dnipro, Ukraine), K. Gashynova (Dnipro, Ukraine), V. Dmytrychenko (Dnipro, Ukraine). HEALTH RELATED QUALITY OF LIFE (HRQoL) AMONG PATIENTS WITH NON CYSTIC FIBROSIS BROCHIECTASIS (BE) IN STABLE PHASE. 789

Member's Comments

No comment yet.

Related content which might interest you: CHARACTERIZATION AND SURVIVAL OF PATIENTS WITH SPINAL MUSCLE ATROPHY TYPE 1 ON HOME MECHANICAL VENTILATION PROGRAM OF MINISTRY OF HEALTH, CHILE Source: International Congress 2017 – Latest insights into functional capacity, muscle weakness and physical activity in chronic lung diseases Year: 2017 NON-CYSTIC FIBROSIS (CF) BRONCHIECTASIS: A 5-YEAR RETROSPECTIVE STUDY WITH A FOCUS ON PATIENTS WITH PRIMARY IMMUNODEFICIENCIES (PID) Source: International Congress 2018 – Management of bronchiectasis and large airway diseases Year: 2018 SPECIALIZED COACHING AT HOME AND DIGITAL TOOLS IMPROVE THE LEVEL OF PHYSICAL ACTIVITY AMONG CYSTIC FIBROSIS PATIENTS Source: International Congress 2017 – Best abstracts in the management of chronic respiratory diseases Year: 2017 FACTORS INFLUENCING PHARMACOLOGICAL TREATMENT IN COPD PATIENTS  ENROLED IN AN INTEGRATED DISEASE MANAGEMENT PROGRAMME (IDMP) Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet? Year: 2018 MULTIDISCIPLINARY APPROACH IN THE EVALUATION AND MANAGEMENT OF PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA. A SINGLE CENTER EXPERIENCE. Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside Year: 2020 DIFFUSING CAPACITY (DLCO) AS A POTENTIAL SURROGATE MARKER FOR SCLERODERMA RELATED LUNG DISEASE– DATA FROM THE GERMAN NETWORK FOR SYSTEMIC SCLEROSIS Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 EVOLUTION OF PATIENTS WITH BRONCHIOLITIS OBLITERANS SYNDROME (BOS) SECONDARY TO ALLOGENIC HAEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) Source: International Congress 2019 – Clinical problems Year: 2019 INSPIRATORY MUSCLE TRAINING BASED ON THE ANAEROBIOSIS THRESHOLD ON THE FUNCTIONAL CAPACITY OF PATIENTS SUBMITTED TO CORONARY ARTERIAL BYPASS GRAFTING: RANDOMIZED AND CONTROLLED CLINICAL TRIAL Source: International Congress 2019 – Cardiopulmonary exercise testing Year: 2019 EVALUATION OF SMALL AIRWAY DISEASE (SAD) IN ASTHMA. CONCORDANCES AND DISCREPANCES BETWEEN DIFFERENT TECHNIQUES. Source: International Congress 2019 – Clinical approach to asthma management Year: 2019 PSYCHOLOGICAL FACTORS PREDICTIVE OF QUALITY OF LIFE IN PATIENTS WITH INTERSTITIAL PULMONARY DISEASE Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis Year: 2020 SLEEP APNOEA AS AN INDEPENDENT RISK FACTOR FOR CARDIOVASCULAR DISEASE: CURRENT EVIDENCE, BASIC MECHANISMS AND RESEARCH PRIORITIES. Source: Eur Respir J 2007; 29: 614 Year: 2007 BACTERIAL IMMUNOTHERAPY IN COPD AND/OR BRONCHIECTASIS FREQUENT EXACERBATOR PATIENTS. A RETROSPECTIVE STUDY. Source: International Congress 2018 – Integrated care and non-pharmacological management of COPD Year: 2018 IMPROVING HOME OXIGEN THERAPY IN PATIENTS WITH INTERSTITIAL LUNG DISEASES (ILDs): APPLICATION OF A PORTABLE NON-INVASIVE VENTILATION (NIV) DEVICE Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis Year: 2019 DEVELOPMENT OF A DIGITAL TELEREHABILITATION SOLUTION: ANALYSIS OF THE NEEDS OF PATIENTS WITH CHRONIC DISEASES Source: International Congress 2017 – Latest insights into chronic care Year: 2017 CARACTERISTICS OF A PROSPECTIVE COHORT OF PATIENTS WITH IPAF (INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES) BY NEUMOLOGISTS AND REUMATOLOGISTS OF MADRID. IPAF-NEREM STUDY Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause Year: 2020 CARDIOVASCULAR RISK (CVR) AND EFFECTS ON THE QUALITY OF LIFE AFTER A PHYSICAL REHABILITATION PROGRAM ON COPD PATIENTS BASED ON THEIR PHENOTYPE: EXACERBATOR (E) OR NON-EXACERBATOR (NE) Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases Year: 2021 PAIN AND FRAILTY IN COPD PATIENTS: RELATIONSHIP AND IMPACT ON WELLBEING AND HEALTH STATUS Source: International Congress 2018 – Patient-reported outcomes and scores in COPD Year: 2018 HEART VARIABILITY IN THE PRESENCE OF PSYCHOLOGICAL STRESS AND QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care Year: 2020 USEFULNESS OF MIRNAS AS PREDICTORS OF LUNG CANCER IN PATIENTS WITH COPD. A PILOT SUTDY Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases Year: 2021